Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Blows FM"'
Autor:
Spurdle, AB, Couch, FJ, Parsons, MT, McGuffog, L, Barrowdale, D, Bolla, MK, Wang, Q, Healey, S, Schmutzler, RK, Wappenschmidt, B, Rhiem, K, Hahnen, E, Engel, C, Meindl, A, Ditsch, N, Arnold, N, Plendl, H, Niederacher, D, Sutter, C, Wang-Gohrke, S, Steinemann, D, Preisler-Adams, S, Kast, K, Varon-Mateeva, R, Ellis, S, Frost, D, Platte, R, Perkins, J, Gareth Evans, D, Izatt, L, Eeles, R, Adlard, J, Davidson, R, Cole, T, Scuvera, G, Manoukian, S, Bonanni, B, Mariette, F, Fortuzzi, S, Viel, A, Pasini, B, Papi, L, Varesco, L, Balleine, R, Nathanson, KL, Domchek, SM, Offitt, K, Jakubowska, A, Lindor, N, Thomassen, M, Jensen, UB, Rantala, J, Borg, Å, Andrulis, IL, Miron, A, Hansen, TVO, Caldes, T, Neuhausen, SL, Toland, AE, Nevanlinna, H, Montagna, M, Garber, J, Godwin, AK, Osorio, A, Factor, RE, Terry, MB, Rebbeck, TR, Karlan, BY, Southey, M, Rashid, MU, Tung, N, Pharoah, PDP, Blows, FM, Dunning, AM, Provenzano, E, Hall, P, Czene, K, Schmidt, MK, Broeks, A, Cornelissen, S, Verhoef, S, Fasching, PA, Beckmann, MW, Ekici, AB, Slamon, DJ, Bojesen, SE, Nordestgaard, BG
Publikováno v:
Spurdle, AB; Couch, FJ; Parsons, MT; McGuffog, L; Barrowdale, D; Bolla, MK; et al.(2014). Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research, 16(1), 1-16. doi: 10.1186/s13058-014-0474-y. UCLA: Retrieved from: http://www.escholarship.org/uc/item/24p313p5
© 2014 Spurdle et al. Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or BRCA2 germline mutation carriers differs from that of individuals with no known mutation. Histopathological features thus have u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::dc7673aca9bed63daf5ef3c4e551a6fa
http://www.escholarship.org/uc/item/24p313p5
http://www.escholarship.org/uc/item/24p313p5
Autor:
Fagerholm, R, Khan, S, Schmidt, MK, García-Closas, M, Heikkilä, P, Saarela, J, Beesley, J, Jamshidi, M, Aittomäki, K, Liu, J, Ali, HR, Andrulis, IL, Beckmann, MW, Behrens, S, Blows, FM, Brenner, H, Chang-Claude, J, Couch, FJ, Czene, K, Fasching, PA, Figueroa, J, Floris, G, Glendon, G, Guo, Q, Hall, P, Hallberg, E, Hamann, U, Holleczek, B, Hooning, MJ, Hopper, JL, Jager, A, Kabisch, M, KConFab/AOCS Investigators, Keeman, R, Kosma, V-M, Lambrechts, D, Lindblom, A, Mannermaa, A, Margolin, S, Provenzano, E, Shah, M, Southey, MC, Dennis, J, Lush, M, Michailidou, K, Wang, Q, Bolla, MK, Dunning, AM, Easton, DF, Pharoah, PDP, Chenevix-Trench, G, Blomqvist, C, Nevanlinna, H
TP53 overexpression is indicative of somatic TP53 mutations and associates with aggressive tumors and poor prognosis in breast cancer. We utilized a two-stage SNP association study to detect variants associated with breast cancer survival in a TP53-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dedfbcfedba701ba9ae60c81a27d8e32
Autor:
Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C, Ali, H Raza, Dawson, Sarah-Jane, Blows, Fiona M, Provenzano, Elena, Pharoah, Paul D, Caldas, Carlos
Publikováno v:
Breast Cancer Research; 2011, Vol. 13 Issue 6, pR118-R118, 1p
Autor:
Grootes I; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, CB1 8RN, UK. Electronic address: ig345@medschl.cam.ac.uk., Keeman R; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Molecular Pathology, Amsterdam, 1066 CX, the Netherlands., Blows FM; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, CB1 8RN, UK., Milne RL; Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Victoria, 3004, Australia; The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, 3010, Australia; Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, Victoria, 3168, Australia., Giles GG; Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, Victoria, 3004, Australia; The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, 3010, Australia; Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, Victoria, 3168, Australia., Swerdlow AJ; The Institute of Cancer Research, Division of Genetics and Epidemiology, London, SM2 5NG, UK; The Institute of Cancer Research, Division of Breast Cancer Research, London, SW7 3RP, UK., Fasching PA; University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, Los Angeles, CA, 90095, USA; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Department of Gynecology and Obstetrics, Erlangen, 91054, Germany., Abubakar M; National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD, 20850, USA., Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON, M5G 1X5, Canada; University of Toronto, Department of Molecular Genetics, Toronto, ON, M5S 1A8, Canada., Anton-Culver H; University of California Irvine, Department of Medicine, Genetic Epidemiology Research Institute, Irvine, CA, 92617, USA., Beckmann MW; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Department of Gynecology and Obstetrics, Erlangen, 91054, Germany., Blomqvist C; University of Helsinki, Department of Oncology, Helsinki University Hospital, Helsinki, 00290, Finland; Örebro University Hospital, Department of Oncology, Örebro, 70185, Sweden., Bojesen SE; Copenhagen University Hospital, Copenhagen General Population Study, Herlev and Gentofte Hospital, Herlev, 2730, Denmark; Copenhagen University Hospital, Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Herlev, 2730, Denmark; University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, 2200, Denmark., Bolla MK; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, CB1 8RN, UK., Bonanni B; IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, 20141, Italy., Briceno I; Universidad de La Sabana, Medical Faculty, Bogota, 140013, Colombia., Burwinkel B; German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080, Heidelberg, 69120, Germany; University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, 69120, Germany., Camp NJ; University of Utah, Department of Internal Medicine and Huntsman Cancer Institute, Salt Lake City, UT, 84112, USA., Castelao JE; Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Oncology and Genetics Unit, Vigo, 36312, Spain., Choi JY; Seoul National University Graduate School, Department of Biomedical Sciences, Seoul, 03080, South Korea; Seoul National University, Cancer Research Institute, Seoul, 03080, South Korea; Seoul National University Medical Research Center, Institute of Health Policy and Management, Seoul, 03080, South Korea., Clarke CL; University of Sydney, Westmead Institute for Medical Research, Sydney, New South Wales, 2145, Australia., Couch FJ; Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, 55905, USA., Cox A; University of Sheffield, Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, Sheffield, S10 2TN, UK., Cross SS; University of Sheffield, Academic Unit of Pathology, Department of Neuroscience, Sheffield, S10 2TN, UK., Czene K; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, 171 65, Sweden., Devilee P; Leiden University Medical Center, Department of Pathology, Leiden, 2333 ZA, the Netherlands; Leiden University Medical Center, Department of Human Genetics, Leiden, 2333 ZA, the Netherlands., Dörk T; Hannover Medical School, Gynaecology Research Unit, Hannover, 30625, Germany., Dunning AM; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, CB1 8RN, UK., Dwek M; University of Westminster, School of Life Sciences, London, W1B 2HW, UK., Easton DF; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, CB1 8RN, UK; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, CB1 8RN, UK., Eccles DM; University of Southampton, Faculty of Medicine, Southampton, SO17 1BJ, UK., Eriksson M; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, 171 65, Sweden., Ernst K; University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, 89075, Germany., Evans DG; University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, M13 9WL, UK; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, M13 9WL, UK., Figueroa JD; National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD, 20850, USA; The University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh, EH16 4UX, UK; The University of Edinburgh, Cancer Research UK Edinburgh Centre, Edinburgh, EH4 2XR, UK., Fink V; University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, 89075, Germany., Floris G; Leuven Cancer Institute, University Hospitals Leuven, Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven, 3000, Belgium., Fox S; Peter MacCallum Cancer Center, Melbourne, Victoria, Australia, 3000., Gabrielson M; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, 171 65, Sweden., Gago-Dominguez M; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, 15706, Spain; University of California San Diego, Moores Cancer Center, La Jolla, CA, 92037, USA., García-Sáenz JA; Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, 28040, Spain., González-Neira A; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, 28029, Spain., Haeberle L; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Department of Gynecology and Obstetrics, Erlangen, 91054, Germany., Haiman CA; University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA, 90033, USA., Hall P; Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, 171 65, Sweden; Södersjukhuset, Department of Oncology, Stockholm, 118 83, Sweden., Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, 69120, Germany., Harkness EF; University of Manchester, Manchester Academic Health Science Centre, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester, M13 9PT, UK; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Nightingale & Genesis Prevention Centre, Manchester, M23 9LT, UK; Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Unit, Manchester, M13 9WL, UK., Hartman M; National University of Singapore and National University Health System, Saw Swee Hock School of Public Health, Singapore, 119077, Singapore; National University Health System, Department of Surgery, Singapore, 119228, Singapore., Hein A; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Department of Gynecology and Obstetrics, Erlangen, 91054, Germany., Hooning MJ; Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, 3015 GD, the Netherlands., Hou MF; Kaohsiung Municipal Hsiao-Kang Hospital, Department of Surgery, Kaohsiung, 812, Taiwan., Howell SJ; University of Manchester, Division of Cancer Sciences, Manchester, M13 9PL, UK., Ito H; Aichi Cancer Center Research Institute, Division of Cancer Information and Control, Nagoya, 464-8681, Japan; Nagoya University Graduate School of Medicine, Division of Cancer Epidemiology, Nagoya, 466-8550, Japan., Jakubowska A; Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, 71-252, Poland; Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, 71-252, Poland., Janni W; University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, 89075, Germany., John EM; Stanford University School of Medicine, Department of Epidemiology & Population Health, Stanford, CA, 94305, USA; Stanford Cancer Institute, Stanford University School of Medicine, Department of Medicine, Division of Oncology, Stanford, CA, 94304, USA., Jung A; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, 69120, Germany., Kang D; Seoul National University, Cancer Research Institute, Seoul, 03080, South Korea; Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, 03080, South Korea., Kristensen VN; Oslo University Hospital and University of Oslo, Department of Medical Genetics, Oslo, 0379, Norway; University of Oslo, Institute of Clinical Medicine, Faculty of Medicine, Oslo, 0450, Norway., Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong; The University of Hong Kong, Department of Surgery, Hong Kong; Hong Kong Sanatorium and Hospital, Department of Surgery and Cancer Genetics Center, Hong Kong., Lambrechts D; VIB Center for Cancer Biology, VIB, Leuven, 3001, Belgium; University of Leuven, Laboratory for Translational Genetics, Department of Human Genetics, Leuven, 3000, Belgium., Li J; Genome Institute of Singapore, Human Genetics Division, Singapore, 138672, Singapore., Lubiński J; Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, 71-252, Poland., Manoochehri M; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, 69120, Germany., Margolin S; Södersjukhuset, Department of Oncology, Stockholm, 118 83, Sweden; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, 118 83, Sweden., Matsuo K; Nagoya University Graduate School of Medicine, Division of Cancer Epidemiology, Nagoya, 466-8550, Japan; Aichi Cancer Center Research Institute, Division of Cancer Epidemiology and Prevention, Nagoya, 464-8681, Japan., Taib NAM; University of Malaya, Department of Surgery, Faculty of Medicine, Kuala Lumpur, 50603, Malaysia., Mulligan AM; University of Toronto, Department of Laboratory Medicine and Pathobiology, Toronto, ON, M5S 1A8, Canada; University Health Network, Laboratory Medicine Program, Toronto, ON, M5G 2C4, Canada., Nevanlinna H; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, 00290, Finland., Newman WG; University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, M13 9WL, UK; St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, Manchester, M13 9WL, UK., Offit K; Memorial Sloan Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY, 10065, USA; Memorial Sloan Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY, 10065, USA., Osorio A; Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, 28029, Spain; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain., Park SK; Seoul National University, Cancer Research Institute, Seoul, 03080, South Korea; Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, 03080, South Korea; Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul, 03080, South Korea., Park-Simon TW; Hannover Medical School, Gynaecology Research Unit, Hannover, 30625, Germany., Patel AV; American Cancer Society, Department of Population Science, Atlanta, GA, 30303, USA., Presneau N; University of Westminster, School of Life Sciences, London, W1B 2HW, UK., Pylkäs K; University of Oulu, Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, Oulu, 90570, Finland; Northern Finland Laboratory Centre Oulu, Laboratory of Cancer Genetics and Tumor Biology, Oulu, 90570, Finland., Rack B; University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, 89075, Germany., Radice P; Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, 20133, Italy., Rennert G; Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, 35254, Israel., Romero A; Hospital Universitario Puerta de Hierro, Medical Oncology Department, Madrid, 28222, Spain., Saloustros E; University Hospital of Larissa, Department of Oncology, Larissa, 411 10, Greece., Sawyer EJ; King's College London, School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, London, UK., Schneeweiss A; University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, 69120, Germany; University Hospital and German Cancer Research Center, National Center for Tumor Diseases, Heidelberg, 69120, Germany., Schochter F; University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, 89075, Germany., Schoemaker MJ; The Institute of Cancer Research, Division of Genetics and Epidemiology, London, SM2 5NG, UK., Shen CY; Academia Sinica, Institute of Biomedical Sciences, Taipei, 115, Taiwan; China Medical University, School of Public Health, Taichung, Taiwan., Shibli R; Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, 35254, Israel., Sinn P; University Hospital Heidelberg, Department of Pathology, Institute of Pathology, Heidelberg, 69120, Germany., Tapper WJ; University of Southampton, Faculty of Medicine, Southampton, SO17 1BJ, UK., Tawfiq E; University of Auckland, Auckland, New Zealand., Teo SH; University of Malaya, Department of Surgery, Faculty of Medicine, Kuala Lumpur, 50603, Malaysia; Cancer Research Malaysia, Breast Cancer Research Programme, Subang Jaya, Selangor, 47500, Malaysia., Teras LR; American Cancer Society, Department of Population Science, Atlanta, GA, 30303, USA., Torres D; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, 69120, Germany; Pontificia Universidad Javeriana, Institute of Human Genetics, Bogota, 110231, Colombia., Vachon CM; Mayo Clinic, Department of Quantitative Health Sciences, Division of Epidemiology, Rochester, MN, 55905, USA., van Deurzen CHM; Erasmus University Medical Center, Department of Pathology, Rotterdam, 3015 CN, the Netherlands., Wendt C; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, 118 83, Sweden., Williams JA; University of Utah, Department of Internal Medicine and Huntsman Cancer Institute, Salt Lake City, UT, 84112, USA., Winqvist R; University of Oulu, Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, Oulu, 90570, Finland; Northern Finland Laboratory Centre Oulu, Laboratory of Cancer Genetics and Tumor Biology, Oulu, 90570, Finland., Elwood M; University of Auckland, Auckland, New Zealand., Schmidt MK; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Molecular Pathology, Amsterdam, 1066 CX, the Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, 1066 CX, the Netherlands., García-Closas M; National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD, 20850, USA., Pharoah PDP; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, CB1 8RN, UK; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, CB1 8RN, UK.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 173, pp. 178-193. Date of Electronic Publication: 2022 Aug 04.
Autor:
Fagerholm R; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Khan S; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Heikkilä P; Department of Pathology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Saarela J; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland., Beesley J; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Jamshidi M; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Liu J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore., Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; Department of Pathology, University of Cambridge, Cambridge, UK., Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada., Beckmann MW; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Blows FM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA., Figueroa J; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK.; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Floris G; Leuven Multidisciplinary Breast Center, Department of Oncology, KULeuven, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Glendon G; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada., Guo Q; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Holleczek B; Saarland Cancer Registry, Saarbrücken, Germany., Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia., Jager A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Keeman R; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Kosma VM; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland., Lambrechts D; Vesalius Research Center, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium., Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Mannermaa A; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland., Margolin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Provenzano E; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Blomqvist C; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Department of Oncology, University of Örebro, Örebro, Sweden., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Publikováno v:
Oncotarget [Oncotarget] 2017 Mar 14; Vol. 8 (11), pp. 18381-18398.
Autor:
Newcombe PJ; 1 MRC Biostatistics Unit, Cambridge, UK., Raza Ali H; 2 Cancer Research UK Cambridge Institute, Cambridge, UK.; 3 Department of Pathology, University of Cambridge, Cambridge, UK.; 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Blows FM; 5 Department of Oncology, University of Cambridge, Cambridge, UK., Provenzano E; 6 NIH Cambridge Biomedical Research Centre, Cambridge, UK., Pharoah PD; 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; 5 Department of Oncology, University of Cambridge, Cambridge, UK.; 7 Strangeways Research Laboratory, Cambridge, UK., Caldas C; 2 Cancer Research UK Cambridge Institute, Cambridge, UK.; 4 Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; 5 Department of Oncology, University of Cambridge, Cambridge, UK., Richardson S; 1 MRC Biostatistics Unit, Cambridge, UK.
Publikováno v:
Statistical methods in medical research [Stat Methods Med Res] 2017 Feb; Vol. 26 (1), pp. 414-436. Date of Electronic Publication: 2016 Sep 30.
Autor:
Blows FM; Departments of *Oncology ‡Pathology ¶Public Health and Primary Care †Cancer Research UK Cambridge Institute, University of Cambridge ∥Department of Pathology, Addenbrooke's Hospital NHS Foundation Trust, Cambridge §Medical Research Council Toxicology Unit, Leicester, UK., Ali HR, Dawson SJ, Le Quesne J, Provenzano E, Caldas C, Pharoah PD
Publikováno v:
Applied immunohistochemistry & molecular morphology : AIMM [Appl Immunohistochem Mol Morphol] 2016 Mar; Vol. 24 (3), pp. 221-6.
Autor:
Sung H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, 20850 MD, USA., Garcia-Closas M; Division of Breast Cancer Research, Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 15 Cotswold Rd, Sutton, Surrey, SM2 5NG London, UK., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Blows FM; Department of Oncology, University of Cambridge, Worts Causeway, CB1 8RN Cambridge, UK., Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, CB2 0RE Cambridge, UK., Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, 20850 MD, USA., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, PO Box 700, 00029 HUS Helsinki, Finland., Fagerholm R; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, PO Box 700, 00029 HUS Helsinki, Finland., Heikkilä P; Department of Pathology, Helsinki University Hospital and University of Helsinki, PO Box 400, 00029 Helsinki, Finland., Blomqvist C; Department of Oncology, Helsinki University Hospital and University of Helsinki, PO Box 400, 00029 Helsinki, Finland., Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, 3004 Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, 3010 Victoria, Australia., Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, 3004 Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, 3010 Victoria, Australia., Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, 3010 Victoria, Australia., McLean C; Anatomical Pathology, The Alfred Hospital, Commercial Rd, Prahran, 3181, 3053 Victoria, Australia., Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211 Kuopio, Finland.; Department of Clinical Pathology, Imaging Center, Kuopio University Hospital, PO Box 100, 70029 KYS Kuopio, Finland., Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211 Kuopio, Finland.; Department of Clinical Pathology, Imaging Center, Kuopio University Hospital, PO Box 100, 70029 KYS Kuopio, Finland., Kataja V; Jyväskylä Central Hospital, Central Finland Health Care District, Adm Bldg 6/2, Keskussairaalantie 19, 40620 Jyväskylä, Finland., Sironen R; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211 Kuopio, Finland.; Department of Clinical Pathology, Imaging Center, Kuopio University Hospital, PO Box 100, 70029 KYS Kuopio, Finland., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Stabile 2-42, 200 First Street SW, Rochester, 55905 MN, USA., Olson JE; Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, 55905 MN, USA., Hallberg E; Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, 55905 MN, USA., Olswold C; Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, 55905 MN, USA., Cox A; Sheffield Cancer Research, Department of Oncology, University of Sheffield, Beech Hill Road, S10 2RX Sheffield, UK., Cross SS; Department of Neuroscience, University of Sheffield, Beech Hill Road, S10 2RX Sheffield, UK., Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, 02115 MA, USA., Tamimi RM; Department of Medicine, Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, 181 Longwood Avenue, Boston, 02115 MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, 02115 MA, USA., Eliassen AH; Department of Medicine, Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, 181 Longwood Avenue, Boston, 02115 MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, 02115 MA, USA., Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Bolla MK; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, CB1 8RN Cambridge, UK., Wang Q; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, CB1 8RN Cambridge, UK., Easton D; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, CB1 8RN Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, CB1 8RN Cambridge, UK., Howat WJ; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, CB2 0RE Cambridge, UK., Coulson P; Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Rd, Sutton, Surrey, SM2 5NG London, UK., Pharoah PD; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, CB1 8RN Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, CB1 8RN Cambridge, UK., Sherman ME; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, 20850 MD, USA., Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, 20850 MD, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2016 Feb 02; Vol. 114 (3), pp. 298-304. Date of Electronic Publication: 2015 Dec 17.
Autor:
Sobral-Leite M; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.leite@nki.nl.; Programa de Farmacologia, Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil. m.leite@nki.nl., Wesseling J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl.; Division of Diagnostic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.wesseling@nki.nl., Smit VT; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. V.T.H.B.M.Smit@lumc.nl., Nevanlinna H; University of Helsinki, Helsinki, Finland. Heli.Nevanlinna@hus.fi.; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. Heli.Nevanlinna@hus.fi., van Miltenburg MH; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. m.v.miltenburg@nki.nl., Sanders J; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. jo.sanders@nki.nl., Hofland I; Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. i.hofland@nki.nl., Blows FM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. fmb28@medschl.cam.ac.uk., Coulson P; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. Penny.Coulson@icr.ac.uk., Patrycja G; Breakthrough Breast Cancer Centre, London, UK. patrycja.gazinska@kcl.ac.uk., Schellens JH; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.schellens@nki.nl.; Department of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. j.schellens@nki.nl., Fagerholm R; University of Helsinki, Helsinki, Finland. rainer.fagerholm@helsinki.fi.; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. rainer.fagerholm@helsinki.fi., Heikkilä P; University of Helsinki, Helsinki, Finland. paivi.heikkila@hus.fi.; Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland. paivi.heikkila@hus.fi., Aittomäki K; University of Helsinki, Helsinki, Finland. kristiina.aittomaki@helsinki.fi.; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. kristiina.aittomaki@helsinki.fi., Blomqvist C; University of Helsinki, Helsinki, Finland. carl.blomqvist@helsinki.fi.; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. carl.blomqvist@helsinki.fi., Provenzano E; Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk.; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK. elena.provenzano@addenbrookes.nhs.uk., Ali HR; Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge, UK. Raza.Ali@cruk.cam.ac.uk.; Department of Pathology, University of Cambridge, Cambridge, UK. Raza.Ali@cruk.cam.ac.uk., Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. figueroaj@mail.nih.gov., Sherman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. shermanm@exchange.nih.gov.; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA. shermanm@exchange.nih.gov., Lissowska J; Department of Cancer Epidemiology and Prevention, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. lissowsj@coi.waw.pl., Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. arto.mannermaa@uef.fi.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. arto.mannermaa@uef.fi., Kataja V; Cancer Center, Kuopio University Hospital, Kuopio, Finland. vesa.kataja@ksshp.fi.; Jyväskylä Central Hospital, Jyväskylä, Finland. vesa.kataja@ksshp.fi., Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. veli-matti.kosma@uef.fi.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. veli-matti.kosma@uef.fi., Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.; Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. jaana.hartikainen@uef.fi.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. jaana.hartikainen@uef.fi., Phillips KA; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. Kelly.Phillips@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org.; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Australia. Kelly.Phillips@petermac.org., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. couch.fergus@mayo.edu., Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. olsonj@mayo.edu., Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. vachon.celine@mayo.edu., Visscher D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. visscher.daniel@mayo.edu., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de.; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. h.brenner@dkfz.de., Butterbach K; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. k.butterbach@dkfz.de., Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. v.arndt@dkfz.de., Holleczek B; Saarland Cancer Registry, Saarbrücken, Germany. B.Holleczek@gbe-ekr.saarland.de., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.hooning@erasmusmc.nl., Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.hollestelle@erasmusmc.nl., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. j.martens@erasmusmc.nl., van Deurzen CH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. c.h.m.vandeurzen@erasmusmc.nl., van de Water B; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl., Broeks A; Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. a.broeks@nki.nl., Chang-Claude J; Division of Cancer Epidemiology, Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. j.chang-claude@dkfz-heidelberg.de., Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Georgia.Trench@qimrberghofer.edu.au., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk., Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. paul.pharoah@srl.cam.ac.uk., García-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. Montse.GarciaClosas@icr.ac.uk.; Breakthrough Breast Cancer Centre, London, UK. Montse.GarciaClosas@icr.ac.uk., de Graauw M; Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. m.de.graauw@lacdr.leidenuniv.nl., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. mk.schmidt@nki.nl.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.
Publikováno v:
BMC medicine [BMC Med] 2015 Jul 02; Vol. 13, pp. 156. Date of Electronic Publication: 2015 Jul 02.
Autor:
Ali HR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Pathology, University of Cambridge, Cambridge raza.ali@cruk.cam.ac.uk., Glont SE; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge., Blows FM; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge., Provenzano E; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge., Dawson SJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge., Liu B; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge., Hiller L; Warwick Clinical Trials Unit, University of Warwick, Coventry., Dunn J; Warwick Clinical Trials Unit, University of Warwick, Coventry., Poole CJ; Warwick Clinical Trials Unit, University of Warwick, Coventry., Bowden S; Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Edgbaston, Birmingham., Earl HM; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge., Pharoah PD; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Strangeways Research Laboratory, University of Cambridge, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2015 Jul; Vol. 26 (7), pp. 1488-93. Date of Electronic Publication: 2015 Apr 20.